Dr. Pishvaian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5255 Loughboro Rd NW
Bldg B
Washington, DC 20016Phone+1 202-660-6500Fax+1 202-660-6501
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2004 - 2007- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2001 - 2004
Georgetown University School of MedicineClass of 2001
Certifications & Licensure
MD State Medical License 2010 - 2025
DC State Medical License 2004 - 2024
TX State Medical License 2019 - 2020
VA State Medical License 2001 - 2010- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations Start of enrollment: 2021 Jan 07
Roles: Contact, Principal Investigator
- A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors Start of enrollment: 2020 Aug 17
Roles: Principal Investigator
- Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 Start of enrollment: 2023 Aug 10
Roles: Contact
Publications & Presentations
PubMed
- Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer.Harshabad Singh, Joanne Xiu, Kevin S Kapner, Chen Yuan, Raja R Narayan
Clinical Cancer Research. 2024-11-01 - 1 citationsClinical outcomes of liposomal irinotecan in patients with advanced pancreatic cancer previously treated with conventional irinotecan: A meta-analysis of real-world ev...Amol Gupta, Ana De Jesus-Acosta, Dung Le, Michael Pishvaian, Neeha Zaidi
Cancer. 2024-11-01 - 5 citationsBrightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors.Changhoon Yoo, Angela Lamarca, Hye Jin Choi, Arndt Vogel, Michael J Pishvaian
Future Oncology. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
